CDMO Pharmacovigilance Multiturn Conversations and Prompts

CDMO Pharmacovigilance Data Characteristics

CDMO (Contract Development and Manufacturing Organization) pharmacovigilance data comes from clinical trials and post-market surveillance services provided to pharmaceutical companies. This data includes Individual Case Safety Reports (ICSRs), drug safety database records, clinical study reports, risk management plans, and regulatory submissions. Data updates frequently, sometimes daily or even in real-time, especially during clinical trials and early drug launch phases. Document structures vary, encompassing structured Case Report Forms (CRFs), unstructured medical texts (e.g., handwritten doctor's notes, patient interview records), and semi-structured XML safety reports. Fields include patient demographics, medication history, adverse event descriptions (MedDRA coding), severity, outcome, and causality assessments. Medical terminology and standardization (e.g., WHO Drug Dictionary, MedDRA) are key features.

Constraints from Data Characteristics on Multiturn Conversations and Prompts

High update frequency of CDMO pharmacovigilance data requires multiturn conversation systems to quickly ingest and index the latest information. This prevents misjudgments of safety information due to outdated data. Diverse document structures, especially the large volume of unstructured medical text, means prompt design must effectively extract key adverse event information and context from long texts. This challenges RAG (Retrieval Augmented Generation) recall strategies. Specialized medical terminology and coding systems, like MedDRA, require the multiturn conversation model to possess domain knowledge. Prompts must guide the AI to identify and correctly interpret these terms, avoiding semantic drift. Furthermore, follow-up questions in multiturn conversations about adverse event causality and severity assessments require the system to integrate multi-source information. The system must maintain focus on core safety signals throughout the conversation history to prevent critical information from being lost or diluted across multiple interactions.

Configuration Settings

Configuration Item	Recommended Value	Rationale
`maxContext`	`8` turns	Maintains contextual coherence for complex adverse event analysis while balancing computational resource consumption.
`Chunk size` (Segment Length)	`500` characters	Accommodates medical text length, ensuring each segment contains sufficient semantic information and reducing information fragmentation.
`Recall count` (Recall Count)	`10` items	Increases coverage for retrieving relevant adverse event reports, clinical study data, and guidelines from diverse documents.
`Similarity threshold` (Similarity Threshold)	`0.75`	Ensures recalled documents are highly relevant to user queries, filtering out low-quality or irrelevant information, especially when precise medical terminology is required.
`Rerank result count` (Reranked Return Count)	`5` items	Refines the final information input to the LLM, focusing on the most relevant safety signals and evidence, improving the accuracy of generated responses.
`max_tokens`	`2048`	Provides ample output space for the AI to generate detailed adverse event assessments, explanations, and recommendations.

Three Common Pitfalls

Symptom: The AI provides contradictory or inaccurate descriptions when discussing adverse event causality. Reason: The Similarity threshold (Similarity Threshold) is set too low, leading to the recall of documents not fully relevant to the current adverse event assessment, or the Rerank result count (Reranked Return Count) is too small, failing to prioritize the most critical evidence for the AI.
Symptom: When a user asks for detailed information about an adverse event, the AI cannot provide it or responds with "insufficient information." Reason: maxContext is set too short, causing critical background information mentioned early in the multiturn conversation to be lost, preventing the AI from analyzing the context in depth.
Symptom: When processing new adverse event reports, the AI cannot identify the latest drug batch or dosage information. Reason: Data synchronization mechanisms are improperly configured or update frequency is insufficient, leading to a lack of the latest CDMO production batch or clinical medication data in the knowledge base.

How to Verify Configuration

Simulate various complex adverse event reporting scenarios. Test the AI's ability to retain key medical terminology and background information across multiple turns. Verify that generated explanations are consistent and medically logical.
Randomly select a batch of newly generated adverse event reports. Observe whether the AI can recall and mention the latest version of data, guidelines, or related cases from the knowledge base. This verifies the effectiveness of data update and recall mechanisms.
For specific drugs and adverse reaction types, use multiturn conversations to guide the AI in causality assessment. Check if the AI can logically reason based on the recalled evidence chain and provide supporting justifications. This validates the reasonableness of Similarity threshold (Similarity Threshold) and Rerank result count (Reranked Return Count).

The values provided are common starting points. Measure them against your own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.